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The duplex DNA unwinding ability of seminal plasmin from bovine semen was examined by treatment of plasmid-protein 
complexes with calf thymus topoisomerase I and resolution of the topoisomer distributions by agarose gel electrophoresis. 
Binding of seminal plasmin results in a moderate degree of unwinding of supercoiled plasmid. The elongation of the 
RNA chain by E.coIi RNA polymerase over promoter containing template is not inhibited by seminal plasmin. However, 
the reinitiation of transcription is blocked in such cases indicating that seminal plasmin inhibits transcription by binding 
to the initiation site of RNA polymerase. 
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1. INTRODUCTION 
Seminal plasmin (SPLN), an antimicrobial pro- 
tein from bovine seminal plasma, has been shown 
to be an inhibitor of transcription in Escherichia 
co/i and it does so in vitro by binding strongly to 
RNA polymerase [1,2]. Surprisingly, it has also 
been noted that SPLN binds strongly to DNA, a 
maximum of 1 molecule of SPLN being bound per 
8 base pairs in the case of poly(dA-dT) [2]. Incuba- 
tion of SPLN with the RNA polymerase before the 
start of transcription was necessary for the optimal 
inhibition of transcription. If the template DNA 
was pretreated with SPLN or if it was added at the 
same time at which the transcription was started, 
no inhibition of RNA synthesis was observed [2]. 
The above experiments indicated that once bound 
to the template, SPLN is no longer available for 
binding with the enzyme and hence does not inhibit 
transcription. 
E. coli RNA polymerase has two catalytic sites: 
the substrate binding site or the initiation site and 
the template binding site or the elongation site [3]. 
It appears therefore that SPLN predominantly acts 
Correspondence address: D. Chatterji, C nr -e for Cellular and 
Molecular Biology, Uppal Road, Hyderal ..J 500007, India 
on the initiation site of the enzyme and blocks the 
substrate binding. It has been further shown by 
one of us that SPLN competes with rifampicin, a 
specific inhibitor of the initiation of RNA syn- 
thesis by bacterial RNA polymerase, for binding to 
the enzyme [4]. We report here that SPLN does not 
inhibit the elongation of transcription and in fact 
may facilitate it by unwinding the template. 
2. EXPERIMENTAL 
E. coli RNA polymerase was purified as described [5] from 
250 g of MRE600, RNase I- cells, grown to the log phase in a 
40-I fermentor. The 500 kDa enzyme with the subunit composi- 
tion (u#‘o had a specific activity of 600 units/mg. SPLN was 
purified following the standard procedure developed in this 
laboratory [I], and was found to be completely free from 
RNases. All other chemicals used were of the purest grade 
available. [3H]UTP used for RNA polymerase assay was ob- 
tained from New England Nuclear. Plasmid pBR322 from E. 
coli strain HBlOl was purified after lysing the cells in the 
presence of lysozyme, 1% Brij 35 and 0.4% deoxycholate, and 
subsequently banding over a CsCl-ethidium bromide density 
gradient as described [6]. Calf thymus topoisomerase I was ob- 
tained from Bethesda Research Laboratory, USA. 
The DNA unwinding assay was done according to Hanas et 
al. [7]. Supercoiled plasmid was either initially relaxed by 
topoisomerase I, or pretreated with the unwinding protein 
before the relaxation reaction. The topoisomers thus generated 
were electrophoresed on 1.2% agarose gel in Tris-acetate buffer 
[8]. Electrophoresis was conducted at 40 Vat room temperature 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 389 
Volume 231, number 2 FEBS LETTERS April 1988 
in a BRL minigel setup and the gel was stained with 1 fig/ml of 
ethidium bromide and photographed. A film of topoisomer 
distribution was scanned with a Biomed densitometer using a 
soft laser source. The mean weighted averages of the respective 
distributions were calculated assuming that the individual peak 
heights are proportional to DNA topoisomer concentration [9]. 
SPLN-resistant elongation of RNA chain by E. coli RNA 
polymerase was performed over ADiiiTr DNA, as described 
IlO]. 
3. RESULTS 
The method employed here to detect the specific 
unwinding of the DNA helix by SPLN is as in [ 111, 
which compares the distributions of DNA 
topoisomers resulting from nicking and closing the 
DNA in the presence and the absence of a DNA- 
binding protein. Fig. 1 depicts the unwinding effect 
of SPLN on the topoisomer distribution of 
pBR322. Unwinding is seen as an upward shift in 
the topoisomer distribution. In the middle lane the 
concentration of topoisomerase I was selected such 
that the complete relaxation of the plasmid was ob- 
tained. It is seen clearly from the figure that SPLN 
induces an upward shift in the band distribution of 
the topoisomers (right lane). Fig.2 depicts the laser 
scan data on the unwinding of the plasmid by 
SPLN. The unwinding ability of SPLN essentially 
can be calculated from these scans following the 
method in [ 111. It is seen from the arrows in fig.2a 
and b that the centre of the Gaussian distribution 
lies in between the two most intense bands in the 
case of topoisomerase treated pBR322 (fig.2a). 
This is about 1 ‘/z turns away (540”) from the centre 
of the band pattern when plasmid was relaxed in 
the presence of 20 times molar excess of SPLN 
(fig.2b). 
As mentioned, the template DNA pretreated 
with SPLN can be transcribed efficiently by RNA 
polymerase. It was of interest to find out whether 
such observations merely account for the elonga- 
tion of RNA chains over a natural or synthetic but 
non-specific DNA chain. Fig.3 shows the in vitro 
RNA synthesis over ADrrrT7 DNA, which has a 
single strong promoter (T7Ar) that gives rise to a 
discrete RNA of 6100 nucleotides [12]. The 
template was preincubated with RNA polymerase 
before the addition of the inhibitor or 
triphosphates, It can be seen from fig.3 that within 
12 min of the start of the reaction from Ar pro- 
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Fig.1. Unwinding by bovine seminal plasmin of plasmid 
pBR322. Left lane, pBR322 (80 nM); middle lane, pBR322 
(80 nM) incubated with calf thymus topoisomerase I (10 units) 
at 30°C for 30 min in buffer A containing 70 mM Tris-HCI, pH 
7.5, 0.5 mM DTT, 0.15 M NaCI, 10% glycerol and 10 mM 
MgCl2; right lane, pBR322 (80 nM) pretreated with seminal 
plasmin (1.6pM) in buffer A for 30 min at 37°C before the 
addition of topoisomerase I (10 units), and incubated further in 
the same buffer for 30 min at 30°C. The reaction was stopped 
by the addition of 0.5% sodium dodecyl sulfate and 0.05% 
bromophenol blue. 
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Fig.2. Densitometric trace of the topoisomeric distributton of 
plasmid pBR322 (80 nM) in the absence (a) and presence of 
seminal plasmin (1.6 pM). 
moters one round of RNA synthesis is coming to 
an end and the residual increase in incorporation 
of UTP to RNA product is due to the escape of 
some polymerase molecules from the termination 
signal at 6100 nucleotides [IO]. In any event, no 
reinitiation of RNA synthesis is taking place. 
However, in the absence of SPLN, transcription 
continuously goes on which was characterized by 
monotonous increase in incorporation of UTP to 
the RNA product (not shown). 
Time in minutes 
Fig.3. Seminal plasmin-resistant elongation of RNA synthesis 
over ADrrrT7 DNA. DNA (5 nM) was preincubated with E. co/i 
RNA polymerase (8 nM) for 3 min to allow the promoter 
search. Later, seminal plasmin (100 nM) was added along with 
the substrates and the incorporation [‘HIUTP to the RNA 
product at defined time points were measured. 
4. DISCUSSION 
Bovine seminal plasmin binds both to the DNA 
and bacterial RNA polymerase and therefore the 
exact mechanism by which it inhibits transcription 
could not be established. Normal rate of transcrip- 
tion over SPLN treated template further raised a 
question whether SPLN bound to the template 
DNA is available for the binding with the enzyme. 
We show here that SPLN is a DNA unwinding pro- 
tein and therefore it should facilitate the move- 
ment of RNA polymerase over the DNA chain. 
Using the protocol already established by 
Chamberlin and his group we have carried out 
transcription over specific promoter containing 
DNA both in the presence and absence of SPLN. 
It is clear from the result that the elongation of 
RNA synthesis is not affected in the presence of 
SPLN. However, the initiation of RNA synthesis is 
inhibited. Therefore, it appears that the transcrip- 
tion observed by other workers in the past over 
SPLN-treated templates are mainly the elongation 
of non-specific RNA molecules. 
It is tempting to conclude from the results 
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presented here that SPLN binds to the substrate 
binding site of the enzyme and thereby inhibits the 
transcription. It also explains the competition of 
SPLN with rifampicin for binding to E. coli RNA 
polymerase [4]. 
Acknowledgement: The authors wish to thank N. Sitaram for 
the preparation of seminal plasmin. 
REFERENCES 
[1] Reddy, E.S.P. and Bhargava, P.M. (1979) Nature 279, 
725-728. 
[2] Scheit, K.H., Reddy, E.S.P. and Bhargava, P.M. (1979) 
Nature 279. 728-73 1. 
[31 
[41 
[51 
PI 
171 
PI 
191 
[lOI 
[Ill 
1121 
Chatterji, D., Wu, C.W. and Wu, F.Y.H. (1984) J. Biol. 
Chem. 259, 284-289. 
Sitaram, N. and Chatterji, D. (1985) FEBS Lett. 182, 
77-80. 
Burgess, R. and Jendrisak, J.J. (1975) Biochemistry 14, 
4634-4638. 
Schleif, R.F. and Wensink, P.C. (1981) Practical 
Methods in Molecular Biology, Springer, New York. 
Hanas, J.S., Bogenhangen, D.F. and Wu, C.W. (1984) 
Nucleic Acids Res. 12, 1265-1276. 
Myers, R.M., Kligman, M. and Tjian, R. (1981) J. Biol. 
Chem. 256, 10156-10160. 
Depew, R.E. and Wang, J.C. (1975) Proc. Natl. Acad. 
Sci. USA 72, 4275-4279. 
Chamberlin, M., Kingston, R., Gilman, M., Wiggs, J. 
and DeVera, H. (1983) Methods Enzymol. 101, 540-568. 
Wang, J.C., Jacobsen, J.H. and Saucier, J.M. (1977) 
Nucleic Acids Res. 4, 1225-1241. 
Wiggs, J., Bush, J. and Chamberlin, M. (1979) Cell 16, 
96-109. 
392 
